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雄激素依赖性前列腺癌细胞系 LNCaP 基因表达图谱差异。获得了以下研究结果： 
1. 选用涵盖 18,000 多个转录本，代表 18,000 多个明晰的基因，其中 13,000 多
个为全长基因的美国 Affymetrix 公司的人类全基因组 U133 系列芯片，高通
量分析了 LNCaP／C4-2 细胞中基因表达图谱的变化。 
2. 通过 Affymetrix、GenBank，dbEST，and RefSeq 等网站对 Affymetrix 芯片数
据进行大量的生物信息学分析和文献调研。其中表达量差异在 1倍以上基因
















上调表达，85 个基因在 C4-2 细胞中下调表达。其中有些差异表达的基因如：
IGF-I、IGFBP3 等基因通过人们的深入研究证明在前列腺癌中起重要作用。 
3. 从表达量差异在 2倍以上的 260个基因中选取了 118个基因作为验证芯片结
果的候选基因。通过反向狭缝杂交、传统 RT-PCR 和实时荧光 PCR 方法验证















5. 由于工作量的问题，本实验选取了 205476_at（CCL20）和 217564_s_at（CPS1）
两个基因进行功能初探。理由是 205476_at 的表达差异通过实时荧光 PCR 结
果它的表达量在 C4-2 中上调表达 51.71 倍，217564_s_at 是一个核基因编码
并定位在线粒体基质中起作用的蛋白并且在 C4-2 细胞中下调表达来了 29.96
倍，因此把其作为抑癌基因研究其功能。 
6. 对于候选基因 205476_at（CCL20）已经完成真核和原核基因表达载体构建，
并通过测序确认正确。但是把含有 CCL20 的载体稳定转染 LNCaP 细胞发现不
能形成稳定克隆，推测其高表达对细胞有毒性。而且本实验还完成了制备
CCL20 蛋白抗体的质粒 pGEX4T1-CCL20 的构建，并通过 IPTG 诱导表达证实构


















以把 CPS1 基因稳定转染了 DU-145 细胞，实验发现虽然 DU-145 细胞可以形
成克隆，并在 DNA 水平上可以检测其已经整合到细胞基因组中，但是在 RNA

















































       The vast amount of information available through the human genome 
project .However, the mere sequence information of the whole genome does not 
answer all our questions. What is required at this stage is a complete understanding of 
the function of genes and other parts of the genome so as to uncover how sets of genes 
and their products work together in normal and diseased conditions. DNA microarrays 
are some of the most powerful and versatile tools available, and there are several 
applications of microarray technology in cancer biology. Since cancer is a genetic 
disease arising from the progressive accumulation of many genetic alternations, 
identification of differences in the expression profile of tumor cells in comparison to 
their normal counterpart would provide a better platform for understanding the 
process of tumor formation and development. 
Prostate cancer is a leading cause of cancer-related deaths and the most 
commonly diagnosed cancer in men in the west. By nature, cancer in the prostate 
progresses slowly and can be treated effectively when detected early; however, the 
metastastatic disease presents a major challenge to improve survival rate and 
treatment efficacy. To overcome this problem, it is critical to identify predictors to 
distinguish prostate cancers that will progress and metastasize, and to separate them 
from those that will not progress during the expected lifetime of the patient. 
Metastatic prostate cancer proceeds through a series of distinct states such as 
transformation of normal prostatic epithelial cells to preinvasive primary tumor, 
androgen-dependent invasive cancer, and androgen-independent (AI) metastatic 
disease. These stages of prostate cancer involve multiple molecular changes some of 
which can be implicated to alterations in gene expression.  
Progression to androgen independence (AI) leading to uncontrolled cell growth 
is the main cause of death in prostate cancer. While almost all patients with metastatic 
prostate cancer will initially respond to anti-androgen treatments, the majority will fail 
















gene expression contribute significantly to the development of AI.  
To investigate this we have used an in vitro cell line model of AI prostate cancer 
C4-2 and androgen dependent prostate cancer LNCaP from which we have identified 
a number of differentially expressed genes associated with progression to AI in 
prostate cancer. Our results show that:  
1.Using bioinformation analysis found that 658 genes were differential expressed; 260 
genes were differential expressed by at least two fold.175 genes upregulated and 85 
genes downregulated in C4-2. Such as IGF-1、IGFBP3 gene was included in the 
microarray results. These genes were extensively studied. 
2. In order to verify the results of microarray, we use the method of traditional 
Reverse Transcription PCR; Reverse Slot Blotting; Real time PCR. We had chosen 
118 genes on the basis of differential expression fold. In the verification, we found 48 





gene upregulated in C4-2; 217564_s_at、206624_at、211682_x_at、206700_s_at、
219974_x_at、209348_s_at、213967_at、201909_at、212233_at、203845_at、
203675_at、213479_at gene downregulated in C4-2. 
3. 202016_at、205893_at、209679_s_at、220625_s_at、205597_at、204971_at、
201195_s_at、212192_at、202388_at、206069_s_at、217564_s_at、209813_x_at、
219974_x_at gene expression were influenced by R1881. 
4. In the experiment I had chosen 2 genes for their functional analysis, we constructed 
five plasmids successfully. 
5. I found that transfect the CCL20 to the LNCaP could not generate the stable clone. 
We supposed that the CCL20 excessive expression would poison the cell. We found 
CCL20 could promote the cell proliferation in the transient transfection under the 
method of Brdu incorporation.  
















express, we supposed that CPS1 had mutation.  
7. The results of microarray provided a number of differential expressed genes, but 
these genes functional analysis was the main difficulty. If we could study the 
differential expressed gene function, we would understand the molecular development 
of prostate cancer. 
 


















































列腺癌细胞系 LNCaP 与骨基质 MS 细胞共同接种裸鼠，八周后，对其进行阉割
去势手术，经过一段时间的停顿，LNCaP 细胞和 MS 细胞形成的嵌合肿瘤继续
生长，PSA 分泌增高，四周后进行肿瘤摘除，在体外培养，经细胞学和分子生物
学进行来源鉴定后得到恶化程度较高的雄激素非依赖的 C4 细胞系，若五周后进
行摘除，则命名为 C5 细胞系。将 C4 细胞系再与骨基质成纤维细胞系 MS 共接
种至阉割去势的裸鼠皮下，十二周后摘除肿瘤体外培养，则获得雄激素非依赖具



































     该方法的最大特点在于用很少的步骤可合成大量的 DNA 阵列。如要合成
一段含 N 个碱基的寡核苷酸序列只需 4×N 个化学步骤，可同时合成 4N 个可能
结构。如果用传统的先合成后点样的方法，其工作量的巨大是不可思议的。
Affymetrix 的原位合成技术可制作的点阵密度高达 106/cm2。 





(2)独特的 PM-MM 探针设计 
    基因芯片杂交的灵敏度和特异性是芯片技术的核心，Affymetrix 在探讨了各
种各样的影响因素后，设计出了一种独特的 PM-MM 探针方案。芯片上的每一个




















































Affymetrix 公司的人类全基因组 U133 系列芯片中的 HU133A 涵盖 18,000 多




1.3 运用 Affymetirx 芯片整体研究前列腺癌细胞系表达谱 






通过生物信息学分析 LNCaP 细胞和 C4-2 细胞芯片结果，其中共有 658 个基
因有差异表达，并且表达量差异在 4 倍以上的基因有 260 个；其中 175 个基因在

































     引物和序列测定由上海博亚生物技术有限公司和上海生工完成，引物序列
见附录。 
 
2.1.2   细胞株、菌株 
      大肠杆菌 E.coli DH5a、BL21，黑色素瘤细胞 B16、结肠癌 Caco-2、鼠成
纤维细胞 NIH3T3、肝癌细胞 HePG2、乳腺癌细胞 MCF-7、人前列腺癌雄激素依









限制性内切酶                      Biolab 公司、Takara 公司 
普通 Taq DNA 聚合酶                 上海申能博彩生物公司 
T4 DNA 连接酶                                Takara 公司 
Pfu DNA 聚合酶                      上海申能博彩生物公司 
LA Taq DNA 聚合酶                             Takara 公司 
Super Taq DNA 聚合酶                 上海申能博彩生物公司 
 
2.1.5 常用分子生物学试剂盒 
质粒提取试剂盒（小量提取）                   Promega 公司 
DNA 胶回收试剂盒                            Promega 公司 
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